Research & news
Latest news and information on the diagnosis and treatment of lung cancer and from the European Lung Foundation's network of partners and professionals.
Immunotherapy benefits for lung cancer patients
Discovery of a new type of immune cell that could help identify which patients will benefit most from immunotherapy treatment
Suicide risk elevated among lung cancer patients
People with lung cancer are at greatest risk of committing suicide, says new research presented at the American Thoracic Society's International Conference 2017
Researchers learn more about what causes some people’s lung cancer to return
The studies are part of a major lung cancer research project called TRACERx, which is taking a detailed look at how lung cancer develops in people – including diagnosis, cure and relapse.
Join us at World No Tobacco Day Events in Brussels
WALCE (Women Against Lung Cancer in Europe) is holding two events in partnership with ELF and other organisations at the end of May.
Findings from the BELIEF lung cancer clinical trial
Findings provide further evidence of benefit for combined use of erlotinib and bevacizumab.
Challenges in lung cancer in Europe
A report from Lung Cancer Europe (LuCE) raises awareness with major stakeholders
Patients help to educate healthcare professionals to improve their communication skills
Three people with experience of different lung conditions, including lung cancer, were invited to speak as part of an ERS online communication course.
ERS vision for lung cancer - an optimistic future
View the video from the European Respiratory Society (ERS) where you can hear lung cancer experts talking about the major advances in diagnostics and therapeutics.
Testing for a rare mutation could reveal treatment with crizotinib
Testing for a rare mutation in lung cancer cases could reveal option for treatment with Crizotinib
Blood tests at diagnosis speeds up lung cancer treatment
Blood testing at the time of an individual’s lung cancer diagnosis has been found to speed up treatment decisions regardless of disease stage, according to research due to be presented at the CHEST Annual Meeting 2016 in Los Angeles this week.